Yingxin Sun
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Harnessing exercise to combat chronic diseases: the role of Drp1-Mediated mitochondrial fission.
Journal: Frontiers in cell and developmental biology
Published: August 16, 2024
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments.
Journal: Archiv der Pharmazie
Published: July 24, 2024
Buyang Huanwu Decoction Alleviates Atherosclerosis by Regulating gut Microbiome and Metabolites in Apolipoprotein E-deficient Mice fed with High-fat Diet.
Journal: Journal of physiological investigation
Published: December 06, 2023
Jia-Wei-Kai-Xin-San Treatment Alleviated Mild Cognitive Impairment through Anti-Inflammatory and Antiapoptotic Mechanisms in SAMP8 Mice.
Journal: Mediators of inflammation
Published: April 13, 2023
The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.
Journal: Scientific reports
Published: March 13, 2021
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis.
Journal: Frontiers in cellular and infection microbiology
Published: October 16, 2020
New Classification of Macrophages in Plaques: a Revolution.
Journal: Current atherosclerosis reports
Published: June 20, 2020
Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review.
Journal: Inflammation
Published: October 25, 2019
Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases.
Journal: Journal of cell communication and signaling
Published: August 13, 2019
Lipid, Protein, and MicroRNA Composition Within Mesenchymal Stem Cell-Derived Exosomes.
Journal: Cellular reprogramming
Published: May 22, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026